nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A4—Temozolomide—melanoma	0.202	0.451	CbGbCtD
Argatroban—CYP3A4—Vemurafenib—melanoma	0.11	0.247	CbGbCtD
Argatroban—CYP3A5—Docetaxel—melanoma	0.0972	0.217	CbGbCtD
Argatroban—CYP3A4—Docetaxel—melanoma	0.0379	0.0847	CbGbCtD
Argatroban—F2—leg—melanoma	0.0308	0.238	CbGeAlD
Argatroban—F2—hindlimb—melanoma	0.0275	0.212	CbGeAlD
Argatroban—F2—appendage—melanoma	0.0236	0.182	CbGeAlD
Argatroban—F2—endothelium—melanoma	0.0143	0.11	CbGeAlD
Argatroban—F2—blood vessel—melanoma	0.0132	0.101	CbGeAlD
Argatroban—F2—neck—melanoma	0.00941	0.0725	CbGeAlD
Argatroban—F2—eye—melanoma	0.007	0.0539	CbGeAlD
Argatroban—Angina unstable—Docetaxel—melanoma	0.00666	0.035	CcSEcCtD
Argatroban—Haemorrhage intracranial—Temozolomide—melanoma	0.00616	0.0324	CcSEcCtD
Argatroban—Disseminated intravascular coagulation—Docetaxel—melanoma	0.00471	0.0248	CcSEcCtD
Argatroban—Bullous eruption—Docetaxel—melanoma	0.00425	0.0224	CcSEcCtD
Argatroban—F2—head—melanoma	0.00397	0.0306	CbGeAlD
Argatroban—Atrial fibrillation—Vemurafenib—melanoma	0.00379	0.02	CcSEcCtD
Argatroban—Digestion impaired—Temozolomide—melanoma	0.00378	0.0199	CcSEcCtD
Argatroban—Thrombosis—Carmustine—melanoma	0.0037	0.0195	CcSEcCtD
Argatroban—Pulmonary embolism—Carmustine—melanoma	0.00262	0.0138	CcSEcCtD
Argatroban—Respiratory failure—Temozolomide—melanoma	0.00257	0.0136	CcSEcCtD
Argatroban—Pulmonary embolism—Temozolomide—melanoma	0.00253	0.0133	CcSEcCtD
Argatroban—Sepsis—Dactinomycin—melanoma	0.00243	0.0128	CcSEcCtD
Argatroban—Sepsis—Carmustine—melanoma	0.00227	0.012	CcSEcCtD
Argatroban—Angiopathy—Vemurafenib—melanoma	0.00225	0.0119	CcSEcCtD
Argatroban—Cerebrovascular accident—Bleomycin—melanoma	0.00222	0.0117	CcSEcCtD
Argatroban—Pleural effusion—Docetaxel—melanoma	0.0022	0.0116	CcSEcCtD
Argatroban—Thrombophlebitis—Carmustine—melanoma	0.00219	0.0116	CcSEcCtD
Argatroban—Thrombophlebitis—Temozolomide—melanoma	0.00212	0.0112	CcSEcCtD
Argatroban—Back pain—Vemurafenib—melanoma	0.00209	0.011	CcSEcCtD
Argatroban—Myocardial ischaemia—Docetaxel—melanoma	0.00209	0.011	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Carmustine—melanoma	0.0019	0.01	CcSEcCtD
Argatroban—Cough—Vemurafenib—melanoma	0.00189	0.00994	CcSEcCtD
Argatroban—Infection—Vemurafenib—melanoma	0.00175	0.00923	CcSEcCtD
Argatroban—Respiratory failure—Docetaxel—melanoma	0.00171	0.00902	CcSEcCtD
Argatroban—Pneumonia—Bleomycin—melanoma	0.00169	0.00888	CcSEcCtD
Argatroban—Pulmonary embolism—Docetaxel—melanoma	0.00168	0.00885	CcSEcCtD
Argatroban—Acute coronary syndrome—Bleomycin—melanoma	0.00165	0.0087	CcSEcCtD
Argatroban—Hypotension—Vemurafenib—melanoma	0.00165	0.00868	CcSEcCtD
Argatroban—Myocardial infarction—Bleomycin—melanoma	0.00164	0.00865	CcSEcCtD
Argatroban—Haematuria—Bleomycin—melanoma	0.0016	0.00842	CcSEcCtD
Argatroban—Pneumonia—Dactinomycin—melanoma	0.00157	0.00828	CcSEcCtD
Argatroban—Gastrointestinal disorder—Vemurafenib—melanoma	0.00152	0.00802	CcSEcCtD
Argatroban—Haemoglobin—Bleomycin—melanoma	0.00151	0.00797	CcSEcCtD
Argatroban—Constipation—Vemurafenib—melanoma	0.00151	0.00795	CcSEcCtD
Argatroban—Haemorrhage—Bleomycin—melanoma	0.00151	0.00793	CcSEcCtD
Argatroban—Pulmonary oedema—Docetaxel—melanoma	0.0015	0.00788	CcSEcCtD
Argatroban—Pneumonia—Carmustine—melanoma	0.00147	0.00775	CcSEcCtD
Argatroban—Sepsis—Docetaxel—melanoma	0.00146	0.00768	CcSEcCtD
Argatroban—Urinary tract infection—Carmustine—melanoma	0.00142	0.00749	CcSEcCtD
Argatroban—Pneumonia—Temozolomide—melanoma	0.00142	0.00749	CcSEcCtD
Argatroban—Thrombophlebitis—Docetaxel—melanoma	0.00141	0.00742	CcSEcCtD
Argatroban—Body temperature increased—Vemurafenib—melanoma	0.0014	0.00735	CcSEcCtD
Argatroban—Urinary tract infection—Temozolomide—melanoma	0.00137	0.00724	CcSEcCtD
Argatroban—Haemoglobin—Carmustine—melanoma	0.00132	0.00695	CcSEcCtD
Argatroban—Haemorrhage—Carmustine—melanoma	0.00131	0.00692	CcSEcCtD
Argatroban—Hypersensitivity—Vemurafenib—melanoma	0.0013	0.00685	CcSEcCtD
Argatroban—Atrial fibrillation—Docetaxel—melanoma	0.00129	0.00678	CcSEcCtD
Argatroban—Renal impairment—Docetaxel—melanoma	0.00128	0.00675	CcSEcCtD
Argatroban—Dermatitis bullous—Docetaxel—melanoma	0.00128	0.00672	CcSEcCtD
Argatroban—Haemoglobin—Temozolomide—melanoma	0.00128	0.00672	CcSEcCtD
Argatroban—Haemorrhage—Temozolomide—melanoma	0.00127	0.00669	CcSEcCtD
Argatroban—Cardiac failure—Docetaxel—melanoma	0.00125	0.00659	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00122	0.00643	CcSEcCtD
Argatroban—Diarrhoea—Vemurafenib—melanoma	0.00121	0.00636	CcSEcCtD
Argatroban—Dizziness—Vemurafenib—melanoma	0.00117	0.00615	CcSEcCtD
Argatroban—Angiopathy—Temozolomide—melanoma	0.00115	0.00607	CcSEcCtD
Argatroban—Cough—Bleomycin—melanoma	0.00114	0.00602	CcSEcCtD
Argatroban—Vomiting—Vemurafenib—melanoma	0.00112	0.00591	CcSEcCtD
Argatroban—Chest pain—Bleomycin—melanoma	0.00112	0.00587	CcSEcCtD
Argatroban—Rash—Vemurafenib—melanoma	0.00111	0.00586	CcSEcCtD
Argatroban—Dermatitis—Vemurafenib—melanoma	0.00111	0.00585	CcSEcCtD
Argatroban—Back pain—Carmustine—melanoma	0.00111	0.00583	CcSEcCtD
Argatroban—Headache—Vemurafenib—melanoma	0.00111	0.00582	CcSEcCtD
Argatroban—Confusional state—Bleomycin—melanoma	0.00108	0.00568	CcSEcCtD
Argatroban—Back pain—Temozolomide—melanoma	0.00107	0.00563	CcSEcCtD
Argatroban—Infection—Bleomycin—melanoma	0.00106	0.00559	CcSEcCtD
Argatroban—Nausea—Vemurafenib—melanoma	0.00105	0.00552	CcSEcCtD
Argatroban—Angina pectoris—Docetaxel—melanoma	0.00103	0.00541	CcSEcCtD
Argatroban—Hypotension—Bleomycin—melanoma	0.000999	0.00526	CcSEcCtD
Argatroban—Infection—Dactinomycin—melanoma	0.000991	0.00522	CcSEcCtD
Argatroban—Chest pain—Carmustine—melanoma	0.000974	0.00513	CcSEcCtD
Argatroban—Cough—Temozolomide—melanoma	0.000964	0.00508	CcSEcCtD
Argatroban—Dyspnoea—Bleomycin—melanoma	0.000953	0.00502	CcSEcCtD
Argatroban—Pneumonia—Docetaxel—melanoma	0.000946	0.00498	CcSEcCtD
Argatroban—Confusional state—Carmustine—melanoma	0.000941	0.00496	CcSEcCtD
Argatroban—Infection—Carmustine—melanoma	0.000927	0.00488	CcSEcCtD
Argatroban—Acute coronary syndrome—Docetaxel—melanoma	0.000927	0.00488	CcSEcCtD
Argatroban—Myocardial infarction—Docetaxel—melanoma	0.000922	0.00485	CcSEcCtD
Argatroban—Pain—Bleomycin—melanoma	0.000914	0.00482	CcSEcCtD
Argatroban—Tachycardia—Carmustine—melanoma	0.000911	0.0048	CcSEcCtD
Argatroban—Confusional state—Temozolomide—melanoma	0.00091	0.00479	CcSEcCtD
Argatroban—Infection—Temozolomide—melanoma	0.000896	0.00472	CcSEcCtD
Argatroban—Feeling abnormal—Bleomycin—melanoma	0.000881	0.00464	CcSEcCtD
Argatroban—Hypotension—Carmustine—melanoma	0.000872	0.00459	CcSEcCtD
Argatroban—Pain—Dactinomycin—melanoma	0.000853	0.00449	CcSEcCtD
Argatroban—Haemoglobin—Docetaxel—melanoma	0.000849	0.00447	CcSEcCtD
Argatroban—Body temperature increased—Bleomycin—melanoma	0.000845	0.00445	CcSEcCtD
Argatroban—Haemorrhage—Docetaxel—melanoma	0.000844	0.00445	CcSEcCtD
Argatroban—Dyspnoea—Carmustine—melanoma	0.000832	0.00438	CcSEcCtD
Argatroban—Feeling abnormal—Dactinomycin—melanoma	0.000822	0.00433	CcSEcCtD
Argatroban—Gastrointestinal pain—Dactinomycin—melanoma	0.000816	0.00429	CcSEcCtD
Argatroban—Gastrointestinal disorder—Carmustine—melanoma	0.000806	0.00424	CcSEcCtD
Argatroban—Dyspnoea—Temozolomide—melanoma	0.000804	0.00423	CcSEcCtD
Argatroban—Pain—Carmustine—melanoma	0.000798	0.0042	CcSEcCtD
Argatroban—Constipation—Carmustine—melanoma	0.000798	0.0042	CcSEcCtD
Argatroban—Dyspepsia—Temozolomide—melanoma	0.000794	0.00418	CcSEcCtD
Argatroban—Abdominal pain—Dactinomycin—melanoma	0.000788	0.00415	CcSEcCtD
Argatroban—Body temperature increased—Dactinomycin—melanoma	0.000788	0.00415	CcSEcCtD
Argatroban—Hypersensitivity—Bleomycin—melanoma	0.000788	0.00415	CcSEcCtD
Argatroban—Gastrointestinal disorder—Temozolomide—melanoma	0.000779	0.0041	CcSEcCtD
Argatroban—Constipation—Temozolomide—melanoma	0.000771	0.00406	CcSEcCtD
Argatroban—Pain—Temozolomide—melanoma	0.000771	0.00406	CcSEcCtD
Argatroban—Feeling abnormal—Carmustine—melanoma	0.000769	0.00405	CcSEcCtD
Argatroban—Angiopathy—Docetaxel—melanoma	0.000766	0.00403	CcSEcCtD
Argatroban—Gastrointestinal pain—Carmustine—melanoma	0.000763	0.00402	CcSEcCtD
Argatroban—Feeling abnormal—Temozolomide—melanoma	0.000743	0.00391	CcSEcCtD
Argatroban—Body temperature increased—Carmustine—melanoma	0.000738	0.00389	CcSEcCtD
Argatroban—Abdominal pain—Carmustine—melanoma	0.000738	0.00389	CcSEcCtD
Argatroban—Gastrointestinal pain—Temozolomide—melanoma	0.000738	0.00388	CcSEcCtD
Argatroban—Hypersensitivity—Dactinomycin—melanoma	0.000735	0.00387	CcSEcCtD
Argatroban—Body temperature increased—Temozolomide—melanoma	0.000713	0.00375	CcSEcCtD
Argatroban—Abdominal pain—Temozolomide—melanoma	0.000713	0.00375	CcSEcCtD
Argatroban—Back pain—Docetaxel—melanoma	0.000711	0.00374	CcSEcCtD
Argatroban—Hypersensitivity—Carmustine—melanoma	0.000688	0.00362	CcSEcCtD
Argatroban—Diarrhoea—Dactinomycin—melanoma	0.000682	0.00359	CcSEcCtD
Argatroban—Vomiting—Bleomycin—melanoma	0.00068	0.00358	CcSEcCtD
Argatroban—Rash—Bleomycin—melanoma	0.000674	0.00355	CcSEcCtD
Argatroban—Dermatitis—Bleomycin—melanoma	0.000674	0.00355	CcSEcCtD
Argatroban—Hypersensitivity—Temozolomide—melanoma	0.000665	0.0035	CcSEcCtD
Argatroban—Cough—Docetaxel—melanoma	0.000641	0.00338	CcSEcCtD
Argatroban—Diarrhoea—Carmustine—melanoma	0.000639	0.00336	CcSEcCtD
Argatroban—Nausea—Bleomycin—melanoma	0.000635	0.00334	CcSEcCtD
Argatroban—Vomiting—Dactinomycin—melanoma	0.000634	0.00334	CcSEcCtD
Argatroban—Rash—Dactinomycin—melanoma	0.000629	0.00331	CcSEcCtD
Argatroban—Chest pain—Docetaxel—melanoma	0.000626	0.00329	CcSEcCtD
Argatroban—Dizziness—Carmustine—melanoma	0.000617	0.00325	CcSEcCtD
Argatroban—Diarrhoea—Temozolomide—melanoma	0.000617	0.00325	CcSEcCtD
Argatroban—Confusional state—Docetaxel—melanoma	0.000605	0.00318	CcSEcCtD
Argatroban—Dizziness—Temozolomide—melanoma	0.000596	0.00314	CcSEcCtD
Argatroban—Infection—Docetaxel—melanoma	0.000596	0.00314	CcSEcCtD
Argatroban—Vomiting—Carmustine—melanoma	0.000593	0.00312	CcSEcCtD
Argatroban—Nausea—Dactinomycin—melanoma	0.000592	0.00312	CcSEcCtD
Argatroban—Rash—Carmustine—melanoma	0.000589	0.0031	CcSEcCtD
Argatroban—Dermatitis—Carmustine—melanoma	0.000588	0.0031	CcSEcCtD
Argatroban—Tachycardia—Docetaxel—melanoma	0.000585	0.00308	CcSEcCtD
Argatroban—Headache—Carmustine—melanoma	0.000585	0.00308	CcSEcCtD
Argatroban—Vomiting—Temozolomide—melanoma	0.000574	0.00302	CcSEcCtD
Argatroban—Rash—Temozolomide—melanoma	0.000569	0.00299	CcSEcCtD
Argatroban—Dermatitis—Temozolomide—melanoma	0.000568	0.00299	CcSEcCtD
Argatroban—Headache—Temozolomide—melanoma	0.000565	0.00298	CcSEcCtD
Argatroban—Hypotension—Docetaxel—melanoma	0.000561	0.00295	CcSEcCtD
Argatroban—Nausea—Carmustine—melanoma	0.000554	0.00292	CcSEcCtD
Argatroban—Nausea—Temozolomide—melanoma	0.000536	0.00282	CcSEcCtD
Argatroban—Dyspnoea—Docetaxel—melanoma	0.000535	0.00282	CcSEcCtD
Argatroban—Dyspepsia—Docetaxel—melanoma	0.000528	0.00278	CcSEcCtD
Argatroban—Gastrointestinal disorder—Docetaxel—melanoma	0.000518	0.00273	CcSEcCtD
Argatroban—Constipation—Docetaxel—melanoma	0.000513	0.0027	CcSEcCtD
Argatroban—Pain—Docetaxel—melanoma	0.000513	0.0027	CcSEcCtD
Argatroban—Feeling abnormal—Docetaxel—melanoma	0.000494	0.0026	CcSEcCtD
Argatroban—Gastrointestinal pain—Docetaxel—melanoma	0.000491	0.00258	CcSEcCtD
Argatroban—Abdominal pain—Docetaxel—melanoma	0.000474	0.0025	CcSEcCtD
Argatroban—Body temperature increased—Docetaxel—melanoma	0.000474	0.0025	CcSEcCtD
Argatroban—Hypersensitivity—Docetaxel—melanoma	0.000442	0.00233	CcSEcCtD
Argatroban—Diarrhoea—Docetaxel—melanoma	0.00041	0.00216	CcSEcCtD
Argatroban—Dizziness—Docetaxel—melanoma	0.000397	0.00209	CcSEcCtD
Argatroban—Vomiting—Docetaxel—melanoma	0.000381	0.00201	CcSEcCtD
Argatroban—Rash—Docetaxel—melanoma	0.000378	0.00199	CcSEcCtD
Argatroban—Dermatitis—Docetaxel—melanoma	0.000378	0.00199	CcSEcCtD
Argatroban—Headache—Docetaxel—melanoma	0.000376	0.00198	CcSEcCtD
Argatroban—Nausea—Docetaxel—melanoma	0.000356	0.00188	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—EDNRB—melanoma	0.000177	0.000759	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CA—melanoma	0.000174	0.000745	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ACER3—melanoma	0.000171	0.000736	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—F2RL1—melanoma	0.00017	0.000732	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—GNA11—melanoma	0.000167	0.000717	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—GAB2—melanoma	0.000167	0.000717	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—F2R—melanoma	0.000166	0.000712	CbGpPWpGaD
Argatroban—F2—Hemostasis—RAC1—melanoma	0.000165	0.00071	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—melanoma	0.000164	0.000703	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VEGFA—melanoma	0.000162	0.000696	CbGpPWpGaD
Argatroban—CYP3A4—Tryptophan metabolism—MDM2—melanoma	0.00016	0.000689	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EDNRB—melanoma	0.00016	0.000689	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GRM3—melanoma	0.00016	0.000688	CbGpPWpGaD
Argatroban—F2—Hemostasis—MMP1—melanoma	0.00016	0.000687	CbGpPWpGaD
Argatroban—F2—Hemostasis—CDK2—melanoma	0.000157	0.000674	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCR4—melanoma	0.000157	0.000674	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—melanoma	0.000157	0.000673	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—UGT2B10—melanoma	0.000157	0.000673	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—GNAQ—melanoma	0.000155	0.000666	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—MAPK3—melanoma	0.000153	0.000658	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KISS1—melanoma	0.000152	0.000652	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—GAB2—melanoma	0.000152	0.000651	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—GNA11—melanoma	0.000152	0.000651	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000151	0.000649	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—melanoma	0.000149	0.00064	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—melanoma	0.000149	0.00064	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SKI—melanoma	0.000147	0.000632	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCR1—melanoma	0.000147	0.000632	CbGpPWpGaD
Argatroban—F2—Hemostasis—FN1—melanoma	0.000146	0.000627	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—MAPK1—melanoma	0.000146	0.000627	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HS3ST5—melanoma	0.000146	0.000626	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MC1R—melanoma	0.000145	0.000622	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—PIK3CA—melanoma	0.000145	0.000621	CbGpPWpGaD
Argatroban—F2—Hemostasis—NOS2—melanoma	0.000144	0.000619	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT3—melanoma	0.000143	0.000615	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCR4—melanoma	0.000142	0.000612	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP17A1—melanoma	0.000142	0.00061	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—GNAQ—melanoma	0.000141	0.000605	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—melanoma	0.000141	0.000605	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	0.00014	0.000601	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CG—melanoma	0.00014	0.0006	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GRM1—melanoma	0.000139	0.000597	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCR7—melanoma	0.000139	0.000597	CbGpPWpGaD
Argatroban—F2—Hemostasis—EGF—melanoma	0.000138	0.000593	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SUFU—melanoma	0.000135	0.000581	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT3—melanoma	0.00013	0.000558	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	0.000129	0.000556	CbGpPWpGaD
Argatroban—F2—Hemostasis—IGF1—melanoma	0.000128	0.000549	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CA—melanoma	0.000127	0.000544	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—BCL2L11—melanoma	0.000126	0.000543	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RHOB—melanoma	0.000126	0.000543	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—MMP1—melanoma	0.000126	0.00054	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CD—melanoma	0.000123	0.000527	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HDAC6—melanoma	0.000121	0.000521	CbGpPWpGaD
Argatroban—F2—Hemostasis—ALB—melanoma	0.000121	0.000521	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—EDN1—melanoma	0.00012	0.000517	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	0.00012	0.000514	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP1B1—melanoma	0.00012	0.000513	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	0.000118	0.000506	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CSF2—melanoma	0.000118	0.000505	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCR2—melanoma	0.000115	0.000494	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCL8—melanoma	0.000115	0.000494	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	0.000115	0.000492	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RAC2—melanoma	0.000113	0.000486	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PRKCA—melanoma	0.000113	0.000484	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFC—melanoma	0.000111	0.000479	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—WNT5A—melanoma	0.000111	0.000479	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PLCB4—melanoma	0.00011	0.000474	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EDN1—melanoma	0.000109	0.000469	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CB—melanoma	0.000107	0.00046	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CSF2—melanoma	0.000107	0.000458	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—RAC1—melanoma	0.000105	0.000449	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIP4K2A—melanoma	0.000104	0.000446	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC6A11—melanoma	0.000104	0.000446	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—AKT1—melanoma	0.000103	0.000444	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PRKCA—melanoma	0.000102	0.00044	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MTAP—melanoma	0.000101	0.000434	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—IGF1—melanoma	0.000101	0.000432	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAP2K2—melanoma	0.0001	0.00043	CbGpPWpGaD
Argatroban—F2—Hemostasis—IL2—melanoma	9.83e-05	0.000422	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—F2R—melanoma	9.79e-05	0.00042	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—MMP2—melanoma	9.74e-05	0.000418	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—RAC1—melanoma	9.49e-05	0.000408	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EDNRB—melanoma	9.48e-05	0.000407	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTK2B—melanoma	9.2e-05	0.000395	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LUM—melanoma	9e-05	0.000387	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PHGDH—melanoma	9e-05	0.000387	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GAB2—melanoma	8.95e-05	0.000384	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GNA11—melanoma	8.95e-05	0.000384	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FLT1—melanoma	8.91e-05	0.000383	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CG—melanoma	8.83e-05	0.000379	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HPSE—melanoma	8.83e-05	0.000379	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CUBN—melanoma	8.67e-05	0.000372	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HDAC2—melanoma	8.42e-05	0.000361	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FOXO4—melanoma	8.42e-05	0.000361	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCR4—melanoma	8.42e-05	0.000361	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SDHD—melanoma	8.37e-05	0.000359	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—BSG—melanoma	8.37e-05	0.000359	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CSPG4—melanoma	8.37e-05	0.000359	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—melanoma	8.36e-05	0.000359	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GNAQ—melanoma	8.32e-05	0.000357	CbGpPWpGaD
Argatroban—F2—Hemostasis—NRAS—melanoma	8.25e-05	0.000354	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GPAM—melanoma	8.11e-05	0.000348	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CXCL8—melanoma	8.09e-05	0.000348	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CG—melanoma	8.02e-05	0.000344	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ACER3—melanoma	7.97e-05	0.000342	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAPK3—melanoma	7.9e-05	0.000339	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SYK—melanoma	7.83e-05	0.000336	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CD—melanoma	7.76e-05	0.000333	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT3—melanoma	7.68e-05	0.00033	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NGFR—melanoma	7.68e-05	0.00033	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ITGAV—melanoma	7.68e-05	0.00033	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAPK1—melanoma	7.52e-05	0.000323	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CTNNB1—melanoma	7.47e-05	0.000321	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—UGT2B10—melanoma	7.29e-05	0.000313	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SOCS1—melanoma	7.11e-05	0.000305	CbGpPWpGaD
Argatroban—F2—Hemostasis—KRAS—melanoma	7.1e-05	0.000305	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAP2K1—melanoma	7.1e-05	0.000305	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—S100B—melanoma	7.09e-05	0.000305	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CD—melanoma	7.05e-05	0.000303	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PLA2G6—melanoma	6.89e-05	0.000296	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ERBB4—melanoma	6.78e-05	0.000291	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HS3ST5—melanoma	6.78e-05	0.000291	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CB—melanoma	6.77e-05	0.000291	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN2B—melanoma	6.73e-05	0.000289	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CA—melanoma	6.53e-05	0.00028	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CD86—melanoma	6.5e-05	0.000279	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCL8—melanoma	6.5e-05	0.000279	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EDN1—melanoma	6.45e-05	0.000277	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—melanoma	6.31e-05	0.000271	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CSF2—melanoma	6.31e-05	0.000271	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGF1—melanoma	6.31e-05	0.000271	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL2—melanoma	6.21e-05	0.000267	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—VCAN—melanoma	6.19e-05	0.000266	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—E2F1—melanoma	6.17e-05	0.000265	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CB—melanoma	6.14e-05	0.000264	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PDGFRA—melanoma	6.11e-05	0.000262	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PRKCA—melanoma	6.05e-05	0.00026	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ITGB3—melanoma	6.05e-05	0.00026	CbGpPWpGaD
Argatroban—F2—Hemostasis—HRAS—melanoma	6.04e-05	0.000259	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SPP1—melanoma	5.93e-05	0.000255	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAP2K2—melanoma	5.91e-05	0.000254	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL8—melanoma	5.9e-05	0.000254	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL2—melanoma	5.64e-05	0.000242	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TERT—melanoma	5.62e-05	0.000241	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RAC1—melanoma	5.61e-05	0.000241	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HIF1A—melanoma	5.38e-05	0.000231	CbGpPWpGaD
Argatroban—F2—Hemostasis—AKT1—melanoma	5.33e-05	0.000229	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP17A1—melanoma	5.22e-05	0.000224	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KDR—melanoma	5.14e-05	0.000221	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLCB4—melanoma	5.13e-05	0.00022	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FN1—melanoma	4.95e-05	0.000213	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GNA11—melanoma	4.93e-05	0.000212	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOTCH1—melanoma	4.84e-05	0.000208	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIP4K2A—melanoma	4.83e-05	0.000207	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC6A11—melanoma	4.83e-05	0.000207	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—FASN—melanoma	4.83e-05	0.000207	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC5A5—melanoma	4.75e-05	0.000204	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CD80—melanoma	4.75e-05	0.000204	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CG—melanoma	4.74e-05	0.000203	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APC—melanoma	4.74e-05	0.000203	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KIT—melanoma	4.74e-05	0.000203	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—NRAS—melanoma	4.74e-05	0.000203	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTAP—melanoma	4.7e-05	0.000202	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EGF—melanoma	4.68e-05	0.000201	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GNAQ—melanoma	4.59e-05	0.000197	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CD44—melanoma	4.59e-05	0.000197	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAPK3—melanoma	4.54e-05	0.000195	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—BRAF—melanoma	4.45e-05	0.000191	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP1B1—melanoma	4.4e-05	0.000189	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF1—melanoma	4.34e-05	0.000186	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAPK1—melanoma	4.32e-05	0.000185	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EGFR—melanoma	4.32e-05	0.000185	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAP2K1—melanoma	4.19e-05	0.00018	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PHGDH—melanoma	4.19e-05	0.00018	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LUM—melanoma	4.19e-05	0.00018	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CD—melanoma	4.16e-05	0.000179	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CA—melanoma	4.12e-05	0.000177	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HPSE—melanoma	4.1e-05	0.000176	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—KRAS—melanoma	4.08e-05	0.000175	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CUBN—melanoma	4.03e-05	0.000173	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGF2—melanoma	3.99e-05	0.000171	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SDHD—melanoma	3.89e-05	0.000167	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CSPG4—melanoma	3.89e-05	0.000167	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—BSG—melanoma	3.89e-05	0.000167	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GPAM—melanoma	3.77e-05	0.000162	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CA—melanoma	3.75e-05	0.000161	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MDM2—melanoma	3.73e-05	0.00016	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ERBB2—melanoma	3.68e-05	0.000158	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CB—melanoma	3.63e-05	0.000156	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCB1—melanoma	3.62e-05	0.000155	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL8—melanoma	3.49e-05	0.00015	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HRAS—melanoma	3.47e-05	0.000149	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN1B—melanoma	3.41e-05	0.000146	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT1—melanoma	3.37e-05	0.000145	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP3—melanoma	3.34e-05	0.000143	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2—melanoma	3.33e-05	0.000143	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PRKCA—melanoma	3.33e-05	0.000143	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—melanoma	3.32e-05	0.000142	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ERCC2—melanoma	3.3e-05	0.000142	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCND1—melanoma	3.25e-05	0.00014	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CTNNB1—melanoma	3.22e-05	0.000138	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLA2G6—melanoma	3.2e-05	0.000138	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP9—melanoma	3.15e-05	0.000135	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN1A—melanoma	3.14e-05	0.000135	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTEN—melanoma	3.14e-05	0.000135	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NFKB1—melanoma	3.12e-05	0.000134	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT1—melanoma	3.06e-05	0.000131	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—VCAN—melanoma	2.88e-05	0.000124	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—melanoma	2.83e-05	0.000122	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT3—melanoma	2.8e-05	0.00012	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NRAS—melanoma	2.8e-05	0.00012	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK3—melanoma	2.68e-05	0.000115	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CG—melanoma	2.61e-05	0.000112	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MYC—melanoma	2.61e-05	0.000112	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK1—melanoma	2.55e-05	0.000109	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EGFR—melanoma	2.55e-05	0.000109	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARG—melanoma	2.52e-05	0.000108	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP17A1—melanoma	2.43e-05	0.000104	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KRAS—melanoma	2.41e-05	0.000103	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CD—melanoma	2.29e-05	9.85e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GNA11—melanoma	2.29e-05	9.85e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALB—melanoma	2.27e-05	9.73e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—FASN—melanoma	2.24e-05	9.64e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CA—melanoma	2.21e-05	9.5e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC5A5—melanoma	2.21e-05	9.48e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—melanoma	2.14e-05	9.19e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GNAQ—melanoma	2.13e-05	9.15e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CD44—melanoma	2.13e-05	9.15e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HRAS—melanoma	2.05e-05	8.79e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP1B1—melanoma	2.04e-05	8.78e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CB—melanoma	2e-05	8.59e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTGS2—melanoma	1.98e-05	8.51e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—melanoma	1.96e-05	8.41e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT1—melanoma	1.81e-05	7.76e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTEN—melanoma	1.73e-05	7.42e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCB1—melanoma	1.68e-05	7.23e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PRKCA—melanoma	1.55e-05	6.65e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ERCC2—melanoma	1.54e-05	6.6e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CA—melanoma	1.22e-05	5.23e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CG—melanoma	1.21e-05	5.21e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARG—melanoma	1.17e-05	5.03e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CD—melanoma	1.07e-05	4.58e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALB—melanoma	1.05e-05	4.52e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AKT1—melanoma	9.96e-06	4.28e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CB—melanoma	9.3e-06	3.99e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGS2—melanoma	9.21e-06	3.96e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTEN—melanoma	8.03e-06	3.45e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CA—melanoma	5.67e-06	2.43e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AKT1—melanoma	4.63e-06	1.99e-05	CbGpPWpGaD
